Skip to main content
. 2024 Dec 24;151(1):13. doi: 10.1007/s00432-024-06064-y

Table 3.

Characteristics of exercise program in included RCT´s

Study Description of exercise intervention Intervention start post-surgery Duration of rehabilitation Training frequency [per week] Session duration Overall training sessions Intensity / control of intensity Adherence in training sessions /
(serious) Adverse events

Anderson et al.

2012

a) supervised strength and cardiovascular training

b) supervised and home-based strength and cardiovascular training

c) voluntarily supervised training + home-based training

a) 4–12 weeks

b) after a

c) after b

a) 12 weeks

b) 12 weeks

c) 24 weeks

a) 2x

b) > 1x

c) voluntarily

65 min a) Resistance training: 50% established 1RM weekly increased by 1–5lbs; cardiovascular training: 14–16 RPE 71.2% R:0–97

Bøhn et al.

2021*

a) Group-based moderate to high aerobic and strength exercise

b) home-based exercise

21–28 days 48 weeks

a) 2x

b) 120 min

a) 60 min VO2max not described in detail
Cantarero-Villanueva et al. 2016 Core stabilization exercises

12.0 ± 7.4 months

14.6 ± 10.0 months

8 weeks 3x 20–30 min 22.0 ± 1.1 RPE 88.36% / IG: 2, CG: 1

Courneya et al.

2003

Supervised cycle ergometry sessions

IG: 14 ± 6 months

CG: 14 ± 7 months

15 weeks 3x

Wk1-3: 25 min;

increased by 5 min every third week

44.3 5 min warm-up + cool-down 50% of VO2max; training intensity at 70–75% of VO2max

98.4% /

Adverse events:

IG: 20,8%

CG: 7.1%

Courneya et al.

2007

a) supervised aerobic exercise (AET)

b) supervised resistance exercise (RET) − 9 exercises á 2 sets á 8–12 reps

Not given Mean: 17 weeks 3x

a) Wk1-3: 25 min;

increased by 5 min every third week

a) 60% of VO2max wk1-6, 70% of VO2max wk 7–12, 89% of VO2max wk > 12

b) 60–70% of 1RM increased by 10% if 12 reps completed

AET: 72%

RET: 68.2% /

Adverse events: 2

Falz et al. 2023 Home-based, bodyweight strength-endurance training Not given 24 weeks 2-3x 30 min 1.5 sessions per week (36 overall sessions) Entity-specific, individually performance adapted and heart rate limited; targeted 5–8 CR10 scale

56.4%

Adverse events: 18

Lee et al. 2017

a) home based endurance exercise

b) home based resistance exercise

IG: 10.7 ± 8.8

CG: 8.8 ± 7.2

12 weeks Daily b) 30 min 3000 steps with HR > 65% of estimated HRmax, 18–27 MET-hours per week

> 18 MET-hours: 86.3%

27 MET-hours: 74.5%

Lin et al. 2013* Group based supervised combined aerobic and resistance exercise 37.8 (16.4) days 12 weeks 2x 40–60 min 24 Increasingly from 40–75 of HRmax 73% (17.3)

Murtezani et al.

2014

supervised group moderate intensity aerobic exercise program

19.0 ± 6.9 vs.

19.1 ± 4.8

10 weeks 3x 25 min Increasingly from 50–75 of estimated HRmax and from 25 min to 45 min

Mutrie et al.

2007

a) group based supervised diverse exercise

b) home based exercise session

Not given 12 weeks

a) 2x

b) 1x

45 min 50–72% of age adjusted HRmax
Travier et al. 2015 supervised combined aerobic and muscle strength training within 10 weeks post diagnosis 18 weeks 2x 60 min different aerobic methods according to HR on ventilatory threshold + strength exercises between 45–75% of 1RM (increasing repetitions or intensity) 83% (IQR: 69–91%)
Van Vulpen et al.2016 supervised combined aerobic and muscle strength training within 10 weeks post diagnosis 18 weeks 2x 60 min different aerobic methods according to HR on ventilatory threshold + strength exercises between 45–75% of 1RM (increasing repetitions or intensity) 89% (IQR: 72–97%)

Mean and standard deviation are presented. Other data (median MD, 95% Confidence interval 95%CI; interquartile range IQR; Range R) are marked

HR max maximal reached heart rate, 1RM one repetition maximum, RPE rating of perceived exertion, CR-10 Category-Ratio Scale anchored at 10, MET metabolic equivalent of task, MAP maximal aerobic power

*Excluded for meta-analysis